Nicolas Leupin
Chief Tech/Sci/R&D Officer presso NOVOCURE LIMITED
Patrimonio netto: 918 078 $ in data 31/03/2024
Profilo
Nicolas Leupin is currently the Chief Medical Officer at NovoCure Ltd.
He previously held the same position at Molecular Partners AG from 2019 to 2023 and at argenx SE from 2016 to 2019.
He was also a member of the Swiss Group for Clinical Research.
Leupin holds an MBA from Jones International University and a doctorate from the University of Bern.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NOVOCURE LTD.
0.05% | 27/02/2024 | 51 124 ( 0.05% ) | 799 068 $ | 31/03/2024 |
MOLECULAR PARTNERS AG
0.08% | 31/12/2023 | 29 168 ( 0.08% ) | 119 010 $ | 31/03/2024 |
Posizioni attive di Nicolas Leupin
| Società | Posizione | Inizio |
|---|---|---|
| NOVOCURE LIMITED | Chief Tech/Sci/R&D Officer | 04/01/2024 |
Precedenti posizioni note di Nicolas Leupin
| Società | Posizione | Fine |
|---|---|---|
| MOLECULAR PARTNERS AG | Chief Tech/Sci/R&D Officer | 24/08/2023 |
| ARGENX SE | Chief Tech/Sci/R&D Officer | 01/07/2019 |
| Swiss Group for Clinical Research | Corporate Officer/Principal | - |
Formazione di Nicolas Leupin
| Jones International University | Masters Business Admin |
| University of Bern | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| ARGENX SE | Health Technology |
| Aziende private | 1 |
|---|---|
| Swiss Group for Clinical Research |
- Borsa valori
- Insiders
- Nicolas Leupin
